\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ \\-\\ unremarkable\ \(0\)\
\-\ labs\\:\\ \\ cmp\\,\\ amylase\\,\\ lipase\\ pending\ \(0\)\
\-\ no\\ specific\\ treatment\\ at\\ this\\ time\\.\\ \\ follow\\-up\\ with\\ liver\\ function\\ tests\\ to\\ determine\\ if\\ stable\\ or\\ continuing\\ to\\ rise\\.\ \(0\)\
\-\ selected\\ images\\ \\â\\€\\“\\ ct\\ \\(contrast\\,\\ arterial\\ phase\\)\\ of\\ abdomen\\/pelvis\ \(0\)\
\-\ 1\\.\\ \\ large\\,\\ diffusely\\ infiltrated\\ fatty\\ liver\\ with\\ accessory\\ left\\ lobe\\.\\ \\ compare\\ to\\ density\\ of\\ spleen\\.\\ \\ multiple\\ areas\\ of\\ focal\\ sparing\\ in\\ left\\ lobe\\ that\\ appears\\ nodular\\.\\ \\ \ \(0\)\
\-\ 2\\.\\ \\ area\\ of\\ focal\\ sparing\\ near\\ portal\\ vein\\.\ \(0\)\
\-\ 3\\.\\ \\ area\\ focal\\ sparing\\ in\\ left\\ lobe\\.\\ \\ renal\\ cyst\\ and\\ renal\\ calculi\\.\ \(0\)\
\-\ hepatic\\ fatty\\ infiltration\\ with\\ focal\\ sparing\ \(0\)\
\-\ hepatomegaly\ \(15\)\
\-\ 1\\.\\	metabolic\\/diffuse\\ infiltration\ \(0\)\
\-\ \\â\\€\\¢\\	fatty\\ infiltration\\ \\â\\€\\“\\ etoh\\,\\ drugs\\,\\ toxins\\,\\ guacher\\â\\€\\™s\ \(0\)\
\-\ \\â\\€\\¢\\	carbohydrate\\ \\â\\€\\“\\ diabetes\\,\\ glycogen\\ storage\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\	iron\\ \\â\\€\\“\\ hemochromatosis\ \(0\)\
\-\ \\â\\€\\¢\\	amyloid\\ \\-\\ amyloidosis\ \(0\)\
\-\ 2\\.\\	tumor\ \(0\)\
\-\ 3\\.\\	cysts\ \(0\)\
\-\ 4\\.\\	inflammation\\/infection\ \(0\)\
\-\ 5\\.\\	vascular\\ congestion\ \(0\)\
\-\ nodular\\ appearance\ \(5\)\
\-\ 1\\.\\	focal\\ fat\\ infiltration\\/sparing\ \(1\)\
\-\ 2\\.\\	hepatocellular\\ carcinoma\ \(1\)\
\-\ 3\\.\\	metastases\ \(1\)\
\-\ this\\ is\\ 51\\ year\\ old\\ woman\\ \\ with\\ known\\ history\\ of\\ nephrolithiasis\\ and\\ left\\ renal\\ cyst\\.\\ \\ she\\ was\\ being\\ followed\\ for\\ stones\\ and\\ had\\ long\\ history\\ of\\ abdominal\\/pelvic\\ ct\\â\\€\\™s\\ and\\ kub\\ films\\.\ \(0\)\
\-\ previous\\ non\\-contrast\\ abdominal\\ ct\\ dating\\ back\\ approx\\ 6\\ months\\ showed\\ evidence\\ for\\ diffuse\\ fatty\\ infiltration\\ and\\ hepatomegaly\\.\\ \\ additionally\\,\\ a\\ non\\-contrast\\ ct\\ performed\\ 1\\ month\\ ago\\ showed\\ increased\\ thickness\\ of\\ the\\ pancreatic\\ head\\.\\ \\ a\\ pre\\-\\ and\\ post\\-contrast\\ ct\\ were\\ obtained\\ to\\ evaluate\\ for\\ change\\.\ \(0\)\
\-\ this\\ is\\ a\\ presumptive\\ diagnosis\\ of\\ diffuse\\ fatty\\ liver\\ disease\\.\\ \\ the\\ causes\\ for\\ which\\ are\\ many\\,\\ for\\ instance\\,\\ alcoholism\\,\\ obesity\\,\\ malnutrition\\,\\ steroid\\ therapy\\,\\ and\\ diabetes\\ mellitus\\.\\ laboratory\\ testing\\ of\\ liver\\ function\\ tests\\ could\\ aid\\ in\\ further\\ diagnosis\\.\\ \\ ct\\ imaging\\ is\\ consistent\\ with\\ this\\ diagnosis\\ as\\ the\\ liver\\ appears\\ less\\ dense\\ than\\ the\\ spleen\\.\\ \\ given\\ that\\ the\\ liver\\ findings\\ were\\ discovered\\ incidentally\\ and\\ the\\ patient\\ has\\ been\\ asymptomatic\\ there\\ is\\ no\\ need\\ to\\ aggressively\\ pursue\\ this\\ with\\ further\\ imaging\\ or\\ biopsy\\.\\ \\ however\\,\\ from\\ a\\ medical\\ record\\ review\\,\\ the\\ patient\\ reported\\ that\\ her\\ primary\\ care\\ manager\\ requested\\ that\\ she\\ be\\ taken\\ off\\ acetaminophen\\ because\\ of\\ high\\ liver\\ function\\ tests\\.\\ \\ the\\ results\\ of\\ this\\ test\\ were\\ unavailable\\.\\ so\\ significant\\ delay\\ in\\ diagnosis\\ could\\ lead\\ to\\ long\\-term\\ liver\\ damage\\.\\ \\ furthermore\\,\\ most\\ cases\\ of\\ fatty\\ liver\\ disease\\ will\\ resolve\\ if\\ the\\ etiology\\ is\\ discovered\\ and\\ the\\ offending\\ agent\\ is\\ removed\\.\ \(0\)\
\-\ the\\ appearance\\ of\\ focal\\ fatty\\ sparing\\ is\\ concerning\\ and\\ could\\ misinterpreted\\ as\\ liver\\ tumor\\,\\ primary\\ of\\ metastasis\\.\\ \\ in\\ this\\ case\\,\\ the\\ focal\\ sparing\\ is\\ in\\ a\\ triangular\\ shape\\ near\\ the\\ portal\\ vein\\ which\\ is\\ consistent\\ with\\ fat\\ sparing\\ and\\ not\\ a\\ mass\\.\\ \\ \ \(0\)\
\-\ accessory\\ lobes\\ of\\ liver\\ are\\ normal\\ variant\\ and\\ if\\ asymptomatic\\ require\\ no\\ intervention\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ sparing\\:\\ 0\\.07693710311641105\ \(0\)\
\-\ liver\\:\\ 0\\.07014813121030294\ \(0\)\
\-\ fatty\\:\\ 0\\.0671741180195851\ \(0\)\
\-\ infiltration\\:\\ 0\\.040317189096163\ \(0\)\
\-\ focal\\:\\ 0\\.03697717582027882\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.03329614826312119\ \(0\)\
\-\ tests\\:\\ 0\\.02903709741631698\ \(0\)\
\-\ hepatomegaly\\:\\ 0\\.02673792681537333\ \(0\)\
\-\ function\\:\\ 0\\.023523127097897976\ \(0\)\
\-\ accessory\\:\\ 0\\.022302843194098927\ \(0\)\
\-\ could\\:\\ 0\\.020471155479419172\ \(0\)\
\-\ spleen\\:\\ 0\\.019896150297793902\ \(0\)\
\-\ portal\\:\\ 0\\.01947199268584497\ \(0\)\
\-\ metabolic\\/diffuse\\:\\ 0\\.019081208709884195\ \(0\)\
\-\ guacher\\:\\ 0\\.019081208709884195\ \(0\)\
\-\ infiltration\\/sparing\\:\\ 0\\.019081208709884195\ \(0\)\
\-\ 3\\.\\:\\ 0\\.018986196182731997\ \(0\)\
\-\ diabetes\\:\\ 0\\.01831407335625942\ \(0\)\
\-\ discovered\\:\\ 0\\.01822661574882427\ \(0\)\
\-\ non\\-contrast\\:\\ 0\\.018056829111797082\ \(0\)\
\-\ 2\\.\\:\\ 0\\.017645741180521157\ \(0\)\
\-\ carbohydrate\\:\\ 0\\.01758089013724362\ \(0\)\
\-\ 1\\.\\:\\ 0\\.017332397183750656\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01698891195480883\ \(0\)\
\-\ inflammation\\/infection\\:\\ 0\\.016703260033113395\ \(0\)\
\-\ renal\\:\\ 0\\.016671919152325125\ \(0\)\
\-\ aggressively\\:\\ 0\\.016080571564603047\ \(0\)\
\-\ misinterpreted\\:\\ 0\\.016080571564603047\ \(0\)\
\-\ near\\:\\ 0\\.01600660004999889\ \(0\)\
\-\ ct\\:\\ 0\\.015523424070026532\ \(0\)\
\-\ nodular\\:\\ 0\\.015516925571913037\ \(0\)\
\-\ if\\:\\ 0\\.015056775544030102\ \(0\)\
\-\ lobe\\:\\ 0\\.014930684077425546\ \(0\)\
\-\ toxins\\:\\ 0\\.01486928198032724\ \(0\)\
\-\ glycogen\\:\\ 0\\.01486928198032724\ \(0\)\
\-\ dating\\:\\ 0\\.01486928198032724\ \(0\)\
\-\ acetaminophen\\:\\ 0\\.01486928198032724\ \(0\)\
\-\ compare\\:\\ 0\\.014580252991962472\ \(0\)\
\-\ instance\\:\\ 0\\.014580252991962472\ \(0\)\
\-\ malnutrition\\:\\ 0\\.014580252991962472\ \(0\)\
\-\ this\\:\\ 0\\.014562685050214137\ \(0\)\
\-\ record\\:\\ 0\\.014325311356342593\ \(0\)\
\-\ manager\\:\\ 0\\.014325311356342593\ \(0\)\
\-\ infiltrated\\:\\ 0\\.014097258292148165\ \(0\)\
\-\ abdominal\\/pelvic\\:\\ 0\\.014097258292148165\ \(0\)\
\-\ pursue\\:\\ 0\\.014097258292148165\ \(0\)\
\-\ offending\\:\\ 0\\.014097258292148165\ \(0\)\
\-\ appears\\:\\ 0\\.013769388834620123\ \(0\)\
\-\ pre\\-\\:\\ 0\\.013702622887832246\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.01356722382334102\ \(0\)\
\-\ vein\\:\\ 0\\.01338499273599185\ \(0\)\
\-\ storage\\:\\ 0\\.013368963407686665\ \(0\)\
\-\ alcoholism\\:\\ 0\\.013219628188017939\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.012824992783702022\ \(0\)\
\-\ that\\:\\ 0\\.01277905392691622\ \(0\)\
\-\ were\\:\\ 0\\.012599261926557932\ \(0\)\
\-\ presumptive\\:\\ 0\\.01259693971950759\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.012504728995654057\ \(0\)\
\-\ continuing\\:\\ 0\\.012390640629022039\ \(0\)\
\-\ calculi\\:\\ 0\\.012390640629022039\ \(0\)\
\-\ abdomen\\/pelvis\\:\\ 0\\.012202304315191672\ \(0\)\
\-\ showed\\:\\ 0\\.012129018475860159\ \(0\)\
\-\ etoh\\:\\ 0\\.012113945019693284\ \(0\)\
\-\ kub\\:\\ 0\\.012113945019693284\ \(0\)\
\-\ approx\\:\\ 0\\.012029051701179688\ \(0\)\
\-\ cmp\\:\\ 0\\.011947362679571794\ \(0\)\
\-\ rise\\:\\ 0\\.011947362679571794\ \(0\)\
\-\ amyloid\\:\\ 0\\.011947362679571794\ \(0\)\
\-\ agent\\:\\ 0\\.01186864483504609\ \(0\)\
\-\ further\\:\\ 0\\.011763827453680771\ \(0\)\
\-\ \\,\\:\\ 0\\.011719050455293825\ \(0\)\
\-\ area\\:\\ 0\\.01169626079711804\ \(0\)\
\-\ iron\\:\\ 0\\.01164833597290336\ \(0\)\
\-\ post\\-contrast\\:\\ 0\\.01164833597290336\ \(0\)\
\-\ mellitus\\:\\ 0\\.01164833597290336\ \(0\)\
\-\ aid\\:\\ 0\\.01164833597290336\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.011579615846681324\ \(0\)\
\-\ obesity\\:\\ 0\\.011579615846681324\ \(0\)\
\-\ unavailable\\:\\ 0\\.011579615846681324\ \(0\)\
\-\ amylase\\:\\ 0\\.011385650135231785\ \(0\)\
\-\ lipase\\:\\ 0\\.011324674211061446\ \(0\)\
\-\ furthermore\\:\\ 0\\.011324674211061446\ \(0\)\
\-\ fat\\:\\ 0\\.011250702696457287\ \(0\)\
\-\ selected\\:\\ 0\\.011207645593593317\ \(0\)\
\-\ diffuse\\:\\ 0\\.01119916632197106\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.01105639281231799\ \(0\)\
\-\ primary\\:\\ 0\\.010958373432448902\ \(0\)\
\-\ is\\:\\ 0\\.01095371646204011\ \(0\)\
\-\ resolve\\:\\ 0\\.010940082918339688\ \(0\)\
\-\ nephrolithiasis\\:\\ 0\\.010890322056381465\ \(0\)\
\-\ requested\\:\\ 0\\.010794106120080959\ \(0\)\
\-\ triangular\\:\\ 0\\.010747555892329957\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.010657355250770285\ \(0\)\
\-\ s\\:\\ 0\\.010609383840322888\ \(0\)\
\-\ appearance\\:\\ 0\\.010579682150366414\ \(0\)\
\-\ she\\:\\ 0\\.010384355590710702\ \(0\)\
\-\ drugs\\:\\ 0\\.010218991042736792\ \(0\)\
\-\ long\\-term\\:\\ 0\\.010218991042736792\ \(0\)\
\-\ congestion\\:\\ 0\\.01007929727404075\ \(0\)\
\-\ 51\\:\\ 0\\.010045738428724806\ \(0\)\
\-\ cyst\\:\\ 0\\.009941000588857586\ \(0\)\
\-\ damage\\:\\ 0\\.00988533156259121\ \(0\)\
\-\ steroid\\:\\ 0\\.009765050499485558\ \(0\)\
\-\ concerning\\:\\ 0\\.009707327020952743\ \(0\)\
\-\ shape\\:\\ 0\\.009623529375539994\ \(0\)\
\-\ thickness\\:\\ 0\\.00954285536082737\ \(0\)\
\-\ stones\\:\\ 0\\.009516618649718398\ \(0\)\
\-\ determine\\:\\ 0\\.009365545571935842\ \(0\)\
\-\ diffusely\\:\\ 0\\.009341360938606566\ \(0\)\
\-\ need\\:\\ 0\\.009224332321138437\ \(0\)\
\-\ delay\\:\\ 0\\.009179236894941809\ \(0\)\
\-\ consistent\\:\\ 0\\.009070555276325555\ \(0\)\
\-\ disease\\:\\ 0\\.009069724293608469\ \(0\)\
\-\ pancreatic\\:\\ 0\\.009049327782980222\ \(0\)\
\-\ testing\\:\\ 0\\.008946725534290646\ \(0\)\
\-\ lead\\:\\ 0\\.008868007689764942\ \(0\)\
\-\ variant\\:\\ 0\\.008810792847626078\ \(0\)\
\-\ dense\\:\\ 0\\.008736785564621144\ \(0\)\
\-\ phase\\:\\ 0\\.008700709693441033\ \(0\)\
\-\ imaging\\:\\ 0\\.008666986253054556\ \(0\)\
\-\ tumor\\:\\ 0\\.00862438225805546\ \(0\)\
\-\ require\\:\\ 0\\.00846373083447634\ \(0\)\
\-\ off\\:\\ 0\\.008447756576256377\ \(0\)\
\-\ so\\:\\ 0\\.00841615744331016\ \(0\)\
\-\ incidentally\\:\\ 0\\.008385012989950636\ \(0\)\
\-\ removed\\:\\ 0\\.008339120765598682\ \(0\)\
\-\ left\\:\\ 0\\.008277967699332594\ \(0\)\
\-\ intervention\\:\\ 0\\.00823567777028191\ \(0\)\
\-\ lobes\\:\\ 0\\.008150784451768315\ \(0\)\
\-\ arterial\\:\\ 0\\.008095984001585869\ \(0\)\
\-\ additionally\\:\\ 0\\.008016300077077826\ \(0\)\
\-\ review\\:\\ 0\\.008016300077077826\ \(0\)\
\-\ pending\\:\\ 0\\.008003300024999445\ \(0\)\
\-\ 5\\.\\:\\ 0\\.00797753183775633\ \(0\)\
\-\ \\-\\:\\ 0\\.007929560427308933\ \(0\)\
\-\ metastases\\:\\ 0\\.00790201829013633\ \(0\)\
\-\ test\\:\\ 0\\.00790201829013633\ \(0\)\
\-\ for\\:\\ 0\\.007890780829466613\ \(0\)\
\-\ etiology\\:\\ 0\\.00782905063355124\ \(0\)\
\-\ hepatic\\:\\ 0\\.007724013748497862\ \(0\)\
\-\ taken\\:\\ 0\\.0077126515063200615\ \(0\)\
\-\ specific\\:\\ 0\\.007645702803524913\ \(0\)\
\-\ films\\:\\ 0\\.00763474327548044\ \(0\)\
\-\ stable\\:\\ 0\\.007623838959398281\ \(0\)\
\-\ many\\:\\ 0\\.0076021937573753735\ \(0\)\
\-\ evaluate\\:\\ 0\\.007476680212677647\ \(0\)\
\-\ results\\:\\ 0\\.007466542010702699\ \(0\)\
\-\ 4\\.\\:\\ 0\\.007282424178356705\ \(0\)\
\-\ cysts\\:\\ 0\\.007245580698769192\ \(0\)\
\-\ change\\:\\ 0\\.007209353875488838\ \(0\)\
\-\ causes\\:\\ 0\\.007200391120800458\ \(0\)\
\-\ previous\\:\\ 0\\.007182576187604537\ \(0\)\
\-\ metastasis\\:\\ 0\\.006923695511471702\ \(0\)\
\-\ which\\:\\ 0\\.006905387823560817\ \(0\)\
\-\ ago\\:\\ 0\\.006884694417310062\ \(0\)\
\-\ laboratory\\:\\ 0\\.006816215878472004\ \(0\)\
\-\ reported\\:\\ 0\\.0067425862566576015\ \(0\)\
\-\ care\\:\\ 0\\.006671379106209421\ \(0\)\
\-\ obtained\\:\\ 0\\.006575467750527796\ \(0\)\
\-\ biopsy\\:\\ 0\\.006562106583629352\ \(0\)\
\-\ because\\:\\ 0\\.006470818867069367\ \(0\)\
\-\ being\\:\\ 0\\.00644542852121333\ \(0\)\
\-\ labs\\:\\ 0\\.006432844170855277\ \(0\)\
\-\ long\\:\\ 0\\.006377102837300267\ \(0\)\
\-\ given\\:\\ 0\\.006340723793325417\ \(0\)\
\-\ less\\:\\ 0\\.0062639394032958495\ \(0\)\
\-\ areas\\:\\ 0\\.0062236951758572875\ \(0\)\
\-\ followed\\:\\ 0\\.0062010300246293755\ \(0\)\
\-\ cases\\:\\ 0\\.006161928277015438\ \(0\)\
\-\ unremarkable\\:\\ 0\\.006123520386757707\ \(0\)\
\-\ back\\:\\ 0\\.006101875184734799\ \(0\)\
\-\ density\\:\\ 0\\.006085782157705539\ \(0\)\
\-\ vascular\\:\\ 0\\.006064509237930079\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.006017396085371736\ \(0\)\
\-\ known\\:\\ 0\\.005852924425246363\ \(0\)\
\-\ will\\:\\ 0\\.005786755451037104\ \(0\)\
\-\ medical\\:\\ 0\\.005691146753389619\ \(0\)\
\-\ as\\:\\ 0\\.005595573618589297\ \(0\)\
\-\ no\\:\\ 0\\.005587299679894819\ \(0\)\
\-\ her\\:\\ 0\\.005561497096287739\ \(0\)\
\-\ month\\:\\ 0\\.005548949222512142\ \(0\)\
\-\ to\\:\\ 0\\.005546339070688133\ \(0\)\
\-\ 6\\:\\ 0\\.005524069613365529\ \(0\)\
\-\ in\\:\\ 0\\.0054726913005227916\ \(0\)\
\-\ head\\:\\ 0\\.005245890282627481\ \(0\)\
\-\ carcinoma\\:\\ 0\\.005242267684017027\ \(0\)\
\-\ time\\:\\ 0\\.005224245080604573\ \(0\)\
\-\ performed\\:\\ 0\\.005157095955037487\ \(0\)\
\-\ a\\:\\ 0\\.005150646776864952\ \(0\)\
\-\ however\\:\\ 0\\.005150147306487165\ \(0\)\
\-\ history\\:\\ 0\\.005109153842887807\ \(0\)\
\-\ high\\:\\ 0\\.005061788010988779\ \(0\)\
\-\ months\\:\\ 0\\.005051820984177635\ \(0\)\
\-\ are\\:\\ 0\\.005042744036924683\ \(0\)\
\-\ been\\:\\ 0\\.0050320235702683794\ \(0\)\
\-\ significant\\:\\ 0\\.004973695132151999\ \(0\)\
\-\ therapy\\:\\ 0\\.0049451099485727555\ \(0\)\
\-\ evidence\\:\\ 0\\.004849442821140428\ \(0\)\
\-\ than\\:\\ 0\\.0048464260928966964\ \(0\)\
\-\ and\\:\\ 0\\.004675558590447233\ \(0\)\
\-\ abdominal\\:\\ 0\\.004623201814117133\ \(0\)\
\-\ physical\\:\\ 0\\.004537890193898784\ \(0\)\
\-\ increased\\:\\ 0\\.00452485883506419\ \(0\)\
\-\ 1\\:\\ 0\\.00440113932458811\ \(0\)\
\-\ or\\:\\ 0\\.004335596315860206\ \(0\)\
\-\ woman\\:\\ 0\\.00427251720235694\ \(0\)\
\-\ most\\:\\ 0\\.004270205934476355\ \(0\)\
\-\ contrast\\:\\ 0\\.004140207114302826\ \(0\)\
\-\ exam\\:\\ 0\\.004063276926297702\ \(0\)\
\-\ case\\:\\ 0\\.004046546391487599\ \(0\)\
\-\ large\\:\\ 0\\.00404446413816251\ \(0\)\
\-\ had\\:\\ 0\\.003991016924763438\ \(0\)\
\-\ findings\\:\\ 0\\.003936876484393852\ \(0\)\
\-\ multiple\\:\\ 0\\.0038956839902148676\ \(0\)\
\-\ the\\:\\ 0\\.0038901313877643625\ \(0\)\
\-\ of\\:\\ 0\\.003782590934999624\ \(0\)\
\-\ treatment\\:\\ 0\\.003743759652815773\ \(0\)\
\-\ patient\\:\\ 0\\.0037081901771272205\ \(0\)\
\-\ images\\:\\ 0\\.003548190242314619\ \(0\)\
\-\ has\\:\\ 0\\.003473376559511424\ \(0\)\
\-\ normal\\:\\ 0\\.0028995940575738117\ \(0\)\
\-\ be\\:\\ 0\\.0028522872799652144\ \(0\)\
\-\ there\\:\\ 0\\.0027526310745995424\ \(0\)\
\-\ from\\:\\ 0\\.002741202842325135\ \(0\)\
\-\ not\\:\\ 0\\.002672767687753107\ \(0\)\
\-\ mass\\:\\ 0\\.0025724264219644253\ \(0\)\
\-\ at\\:\\ 0\\.00250598085028492\ \(0\)\
\-\ \\:\\:\\ 0\\.00244648228569408\ \(0\)\
\-\ was\\:\\ 0\\.002139128835960361\ \(0\)\
\-\ year\\:\\ 0\\.0020694919248331486\ \(0\)\
\-\ \\.\\:\\ 0\\.0019209705680382184\ \(0\)\
\-\ old\\:\\ 0\\.0018937978287061788\ \(0\)\
\-\ with\\:\\ 0\\.0017727905468165111\ \(0\)\
\-\ \\(\\:\\ 0\\.0015635535200083561\ \(0\)\
\-\ \\)\\:\\ 0\\.0015444538790331279\ \(0\)\
